Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -23.2 Million USD | 69.87% |
| 2022 | -77.02 Million USD | 17.99% |
| 2021 | -93.92 Million USD | -327.27% |
| 2020 | -21.98 Million USD | 25.3% |
| 2019 | -29.42 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.48 Million USD | -107.62% |
| 2024 Q1 | -1.67 Million USD | 35.0% |
| 2024 Q3 | -3.26 Million USD | 102.84% |
| 2023 Q2 | -6.4 Million USD | 29.11% |
| 2023 Q1 | -9.03 Million USD | 39.32% |
| 2023 FY | -23.2 Million USD | 69.87% |
| 2023 Q4 | -2.58 Million USD | 50.13% |
| 2023 Q3 | -5.17 Million USD | 19.18% |
| 2022 Q2 | -21.06 Million USD | 0.66% |
| 2022 Q1 | -21.2 Million USD | -56.84% |
| 2022 FY | -77.02 Million USD | 17.99% |
| 2022 Q4 | -14.89 Million USD | 24.96% |
| 2022 Q3 | -19.85 Million USD | 5.78% |
| 2021 Q1 | -12.55 Million USD | -14.05% |
| 2021 FY | -93.92 Million USD | -327.27% |
| 2021 Q4 | -13.52 Million USD | 46.4% |
| 2021 Q3 | -25.22 Million USD | 8.47% |
| 2021 Q2 | -27.56 Million USD | -119.49% |
| 2020 Q3 | -2.4 Million USD | -275.04% |
| 2020 FY | -21.98 Million USD | 25.3% |
| 2020 Q4 | -11.01 Million USD | -357.99% |
| 2020 Q2 | -641 Thousand USD | -64000.0% |
| 2020 Q1 | -1000.00 USD | 0.0% |
| 2019 FY | -29.42 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 104.581% |
| Addus HomeCare Corporation | 90.95 Million USD | 125.517% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 344.743% |
| Amedisys, Inc. | 156.39 Million USD | 114.84% |
| American Oncology Network, Inc. | -49.15 Million USD | 52.783% |
| Astrana Health, Inc. | 84.61 Million USD | 127.43% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 387.525% |
| IMAC Holdings, Inc. | -6.37 Million USD | -264.034% |
| biote Corp. | 28.65 Million USD | 180.989% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -88.629% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 120.591% |
| COMPASS Pathways plc | -136.91 Million USD | 83.049% |
| DocGo Inc. | 15.05 Million USD | 254.162% |
| The Ensign Group, Inc. | 255.36 Million USD | 109.088% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 137.219% |
| InnovAge Holding Corp. | -23.18 Million USD | -0.125% |
| Assure Holdings Corp. | -20.08 Million USD | -15.571% |
| The Joint Corp. | -2.07 Million USD | -1019.538% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 87.729% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -47.793% |
| ModivCare Inc. | -139.94 Million USD | 83.416% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 55042.948% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -171.35% |
| Option Care Health, Inc. | 314.59 Million USD | 107.377% |
| P3 Health Partners Inc. | -167.86 Million USD | 86.174% |
| P3 Health Partners Inc. | -167.86 Million USD | 86.174% |
| The Pennant Group, Inc. | 25.16 Million USD | 192.213% |
| Surgery Partners, Inc. | 328 Million USD | 107.076% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -703.747% |
| Talkspace, Inc. | -23.2 Million USD | -0.0% |
| The Oncology Institute, Inc. | -77.01 Million USD | 69.865% |
| The Oncology Institute, Inc. | -77.01 Million USD | 69.865% |